Health care private equity firms, payers and providers are doubling down on mergers and acquisitions as the pandemic reshapes the health care ecosystem, writes Matt Wolf, health care senior analyst at RSM US.
Expectations for the future of health care are changing, which is forcing many organizations to rethink their strategies and balance sheets. Meanwhile, investor appetite for health care companies has never been higher. This confluence of factors will sustain deal activity for some time. Much of the future activity will be driven by digital health and health care “light” sectors. Read more.
